These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 228871
1. Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide. Taniyama T, Holden HT. Cell Immunol; 1979 Dec; 48(2):369-74. PubMed ID: 228871 [No Abstract] [Full Text] [Related]
2. The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process. Fidler IJ. J Immunol; 1981 Oct; 127(4):1719-20. PubMed ID: 6974201 [No Abstract] [Full Text] [Related]
3. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP. Leclerc C, Juy D, Bourgeois E, Chedid L. Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275 [No Abstract] [Full Text] [Related]
4. Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs. Uemiya M, Saiki I, Kusama T, Azuma I, Yamamura Y. Microbiol Immunol; 1979 Jun; 23(8):821-3. PubMed ID: 120487 [No Abstract] [Full Text] [Related]
5. Effect of synthetic muramyl dipeptide (MDP) on differentition of myeloid leukemic cells. Akagawa KS, Tokunaga T. Microbiol Immunol; 1980 Jun; 24(10):1005-11. PubMed ID: 6936604 [No Abstract] [Full Text] [Related]
7. Activation of tumoricidal properties in murine macrophages by intravenous injection of muramyl dipeptide encapsulated within liposomes as a treatment for spontaneous metastasis. Fidler IJ, Poste G. Prog Clin Biol Res; 1981 Jun; 75B():257-67. PubMed ID: 7323097 [No Abstract] [Full Text] [Related]
11. Augmentation of mouse natural killer cell activity by muramyl dipeptide and its analogs. Sharma SD, Tsai V, Krahenbuhl JL, Remington JS. Cell Immunol; 1981 Jul 15; 62(1):101-9. PubMed ID: 7261067 [No Abstract] [Full Text] [Related]
12. Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice. Fraser-Smith EB, Waters RV, Matthews TR. Infect Immun; 1982 Jan 15; 35(1):105-10. PubMed ID: 7054119 [Abstract] [Full Text] [Related]
13. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro]. Reisser D, Jeannin JF, Martin F. C R Seances Acad Sci III; 1982 Nov 08; 295(8):485-8. PubMed ID: 6819063 [Abstract] [Full Text] [Related]
16. In vitro inhibition of murine B-cell tumor growth by MDP, MDP(D-D) and Vaccin is mediated by macrophages. Moras ML, Phillips NC, Bahr GM, Chedid L. Int J Immunopharmacol; 1985 Nov 08; 7(4):515-24. PubMed ID: 3876296 [Abstract] [Full Text] [Related]
19. Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines. Iribe H, Koga T, Onoue K, Kotani S, Kusumoto S, Shiba T. Cell Immunol; 1981 Oct 08; 64(1):73-83. PubMed ID: 7028277 [No Abstract] [Full Text] [Related]
20. Release of superoxide anion and enhanced candidacidal activity as a manifestation of macrophage activation: studies with muramyl dipeptide. Cummings NP, Pabst MJ, Johnston RB. Adv Exp Med Biol; 1982 Oct 08; 141():179-87. PubMed ID: 6283823 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]